Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Mar ETF MARW Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MARW Stock Details MARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	44,083 +5,308	+14%	+$189K	﹤0.01%	1738
2026 Q1	$1.32M	Buy	38,775 +3,368	+10%	+$116K	﹤0.01%	1936
2025 Q4	$1.22M	Buy	35,407 +1,092	+3%	+$37K	﹤0.01%	1941
2025 Q3	$1.15M	Buy	34,315 +229	+0.7%	+$7.57K	﹤0.01%	1941
2025 Q2	$1.11M	Buy	34,086 +2,315	+7%	+$72.5K	﹤0.01%	1860
2025 Q1	$985K	Buy	31,771 +7,298	+30%	+$229K	﹤0.01%	1877
2024 Q4	$760K	Sell	24,473 -5,184	-17%	-$160K	﹤0.01%	2087
2024 Q3	$903K	Sell	29,657 -920	-3%	-$27.5K	﹤0.01%	1929
2024 Q2	$902K	Sell	30,577 -44,578	-59%	-$1.29M	﹤0.01%	1842
2024 Q1	$2.16M	Buy	+75,155	New	+$2.12M	0.01%	1212

Other funds holding MARW

CRWM

Castle Rock Wealth Management Walnut Creek, California $509M AUM 36.93% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

CWS

Cypress Wealth Services Palm Desert, California $815M AUM 27.86% 1-Year Est. Return

FFN

Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Cambridge Investment Research Advisors's MARW Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM U.S. Equity Buffer20 Mar ETF (MARW) stake by 14% in Q2 2026, buying an estimated $189K and bringing the position to 44,083 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1738.

Cambridge Investment Research Advisors first reported a position in MARW in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.16M in Q1 2024. 12 funds tracked by Wall St. Rank hold MARW as of Q2 2026.

Cambridge Investment Research Advisors held 44,083 shares of AllianzIM U.S. Equity Buffer20 Mar ETF worth $1.59M as of Q2 2026.
Cambridge Investment Research Advisors bought 5,308 AllianzIM U.S. Equity Buffer20 Mar ETF shares in Q2 2026, an estimated $189K.
AllianzIM U.S. Equity Buffer20 Mar ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1738 holding.
Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Mar ETF in Q1 2024 and has held it in 10 quarters since.
Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer20 Mar ETF position peaked at $2.16M in Q1 2024.
12 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Mar ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.